Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT04567225
What this trial is testing

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

Who this might be right for
Diabetic KetoacidosisType 1 DiabetesType 2 Diabetes
The Cleveland Clinic 39
Early research (Phase 1)Study completedNCT00810589
What this trial is testing

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial

Who this might be right for
Diabetes, Type I
Medical University of Graz 30
Large-scale testing (Phase 3)Ended earlyNCT00521820
What this trial is testing

Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

Who this might be right for
Diabetes Mellitus
Takeda 518
Testing effectiveness (Phase 2)WithdrawnNCT06651515
What this trial is testing

The Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia

Who this might be right for
Diabetes Mellitus Type 1
Seraxis
Early research (Phase 1)Study completedNCT03176524
What this trial is testing

A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM

Who this might be right for
Type 1 Diabetes Mellitus
Adocia 27
Testing effectiveness (Phase 2)UnknownNCT05448820
What this trial is testing

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Advanced SarcomaMetastatic SarcomaSoft Tissue Sarcoma
Tracon Pharmaceuticals Inc. 15
Post-approval studies (Phase 4)Study completedNCT00327418
What this trial is testing

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

Who this might be right for
Major Coronary EventCerebrovascular AccidentCoronary Artery Bypass Graft+2 more
Pfizer 2,800
Not applicableStudy completedNCT03096535
What this trial is testing

Cold Induced Activation of Brown Adipose Tissue in Humans

Who this might be right for
Adipose Tissue, BrownBrown Adipose TissueBrown Fat+8 more
Susanna Søberg 16
Not applicableStudy completedNCT00881543
What this trial is testing

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Who this might be right for
Diabetes Type 2
University of Sao Paulo General Hospital 45
Not applicableStudy completedNCT01545791
What this trial is testing

Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,037
Large-scale testing (Phase 3)Study completedNCT03767543
What this trial is testing

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 265
Not applicableUnknownNCT03607604
What this trial is testing

Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Maturity-onset Diabetes of the Young
Imperial College London Diabetes Centre 778
Post-approval studies (Phase 4)Study completedNCT00965549
What this trial is testing

Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 463
Not applicableStudy completedNCT00639964
What this trial is testing

Exploration of the Lipid Metabolism During the Diabetic Pregnancies

Who this might be right for
PregnancyPregnancy in DiabetesType 1 Diabetes Mellitus+1 more
University Hospital, Lille 186
Early research (Phase 1)Study completedNCT02184455
What this trial is testing

Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment

Who this might be right for
Diabetes Type IDiabetes Type II
Dr. Paul F. Gratzer 11
Early research (Phase 1)Study completedNCT01821079
What this trial is testing

A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation

Who this might be right for
Healthy
Pfizer 12
Not applicableLooking for participantsNCT07650682
What this trial is testing

Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

Who this might be right for
Type 2 DiabetesInsulin Dependent Diabetes
Clinical Nutrition Research Center, Illinois Institute of Technology 25
Early research (Phase 1)Study completedNCT06293742
What this trial is testing

ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants

Who this might be right for
Type 2 Diabetes Mellitus
Eccogene 48
Not applicableNot Yet RecruitingNCT07769138
What this trial is testing

Implementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)

Who this might be right for
Type 1 DiabetesType 2 Diabetes Treated With InsulinHyperglycemia+3 more
Imperial College Healthcare NHS Trust 70
Post-approval studies (Phase 4)Study completedNCT00384085
What this trial is testing

Insulin Glargine "All to Target" Trial

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 588
Next Page